Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Recent Articles

Neuren

Neuren Pharmaceuticals (ASX:NEU) Gets FDA Approval- Is It a Buy?

December 16, 2025

Neuren Pharmaceuticals (ASX: NEU) rose…

Read More
Gorilla Gold

Gorilla Gold (ASX: GG8) Adds 900% More Gold- Time to Buy or Cash Out?

December 16, 2025

Gorilla Gold surges after a…

Read More
FortifAI

FortifAI (ASX:FAI) Acquires NOL8 in a Bold Play to Power the Data Future

December 15, 2025

FortifAI’s NOL8 Acquisition Signals Next-Level…

Read More
fortescue

Fortescue (ASX:FMG) Digs Deeper Into Copper with Alta Acquisition

December 15, 2025

Fortescue’s C$139M Alta Deal Explained…

Read More
Electric optic systems

Electric Optic Systems (ASX:EOS) Lands Major $120M Asia Military Contract, Is It Time to Buy?

December 15, 2025

EOS Fires Up Second High-Energy…

Read More
spacex

SpaceX’s $1.5 Trillion-Dollar Lift Off in Potential 2026 IPO

December 15, 2025

SpaceX Ignites a Trillion-Dollar Push…

Read More
ASX Resources Stocks With Feasibility Studies

Here are 6 ASX Resources Stocks With Feasibility Studies due in 2026!

December 15, 2025

This article outlines 6 ASX…

Read More
Peter Warren Automotive

Peter Warren Automotive (ASX:PWR): When will be its time to shine? Maybe it will be 2026 (if the market recovers)

December 15, 2025

Peter Warren Automotive (ASX:PWR) has…

Read More
South32

Is South32 a Buy After Macquarie’s Upgrade? Here’s What Investors Need to Know

December 15, 2025

South32 (ASX: S32) climbed 3.6% on…

Read More
Alcoa

Alcoa (ASX:AAI) Doubles From 52-Week Low: Buy the Breakout or Take Profits?

December 15, 2025

Alcoa’s (ASX: AAI) share price…

Read More
BMC Minerals

BMC Minerals (ASX: BMC) Surges 25% on ASX Debut: Should You Buy After the IPO Pop?

December 15, 2025

BMC Minerals (ASX: BMC) made…

Read More
Newmont

Newmont (ASX: NEM) Hits Record High After 135% Rally: Is the Gold Giant Still a Buy?

December 15, 2025

Newmont at record highs: buy…

Read More
Gambling

ASX Gambling Stocks: How the Australian Market Works

December 13, 2025

The Australian Securities Exchange (ASX)…

Read More
ASX Gold Stocks

ASX Gold Stocks Surge on Fed Rate Cut: Buy ASX Miners or Take Profits?

December 13, 2025

ASX Gold Stocks: Profits Surge…

Read More
Nickel Industries

Nickel Industries (ASX: NIC) Surges on Quota Approval: Is This Beaten-Down Stock a Buy?

December 13, 2025

Nickel Industries Gains Quota Approval:…

Read More
ANZ

ANZ (ASX:ANZ) Sued by Former CEO Over $13.5m Bonus Cuts: Is 4.7% Yield Worth the Risk?

December 13, 2025

ANZ Group Holdings (ASX: ANZ)…

Read More
disney

Disney Bets Big on AI, Investing US$1B in OpenAI Partnership

December 12, 2025

DIS Joins the AI Race…

Read More
Hazer

Hazer Group (ASX:HZR) Secures MOU to Power Whyalla’s Green Steel Ambition

December 12, 2025

Hazer Signs Binding MOU, Moving…

Read More
metallium

Metallium (ASX:MTM) LOI With ElementUS Marks a Strategic Step Toward US Expansion

December 12, 2025

Metallium’s LOI With ElementUS Turns…

Read More
oracle

Oracle’s (NSDQ:ORCL) Growth Engine Is Running, But on Borrowed Fuel

December 12, 2025

Investors Hit Ctrl+Alt+Sell as Oracle’s…

Read More

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

Neuren Pharmaceuticals (ASX:NEU) Gets FDA Approval- Is It a Buy?

By Ujjwal Maheshwari | December 16, 2025

Neuren Pharmaceuticals (ASX: NEU) rose 2.5% yesterday after the US FDA approved DAYBUE STIX, a new powder formulation of its Rett syndrome treatment. The stock has surged 47% over the past year, significantly outperforming the broader ASX, and now trades at a market capitalisation of around AUD 2.55 billion. For investors watching the healthcare space,…

Read More

Gorilla Gold (ASX: GG8) Adds 900% More Gold- Time to Buy or Cash Out?

By Ujjwal Maheshwari | December 16, 2025

Gorilla Gold surges after a 900% resource increase: what’s next? Gorilla Gold (ASX: GG8) climbed another 5% yesterday after announcing a 900% jump in gold resources at its Comet Vale project in Western Australia. The resource has grown from around 96,000 ounces to 860,000 ounces, a remarkable result for a company that has quietly become…

Read More

FortifAI (ASX:FAI) Acquires NOL8 in a Bold Play to Power the Data Future

By Charlie Youlden | December 15, 2025

FortifAI’s NOL8 Acquisition Signals Next-Level Ambitions in Data Processing FortifAI Limited (ASX:FAI) surged 25% today after announcing a strategic pivot into data processing through an exclusive license to commercialise NOL8 technology. For investors needing context, FortifAI was previously focused on video game development and has worked with major global brands including Lego, Disney, and Sony,…

Read More

Fortescue (ASX:FMG) Digs Deeper Into Copper with Alta Acquisition

By Charlie Youlden | December 15, 2025

Fortescue’s C$139M Alta Deal Explained Fortescue (ASX:FMG) is moving to acquire the remaining 64 percent of Alta Copper Corp, a Canadian explorer focused on Peruvian copper, in a C$139M all cash deal. If completed, this would mark a meaningful expansion of Fortescue’s copper footprint. The board’s decision signals strong confidence in the copper macro backdrop…

Read More

Electric Optic Systems (ASX:EOS) Lands Major $120M Asia Military Contract, Is It Time to Buy?

By Charlie Youlden | December 15, 2025

EOS Fires Up Second High-Energy Laser Sale Electric Optic Systems (ASX:EOS) is moving toward a potential partnership with a South Korean venture to deliver a defence laser contract worth about A$120M. This marks the company’s second sale of a 100 kilowatt class high energy laser weapon system, following an earlier European deal. From what we…

Read More

SpaceX’s $1.5 Trillion-Dollar Lift Off in Potential 2026 IPO

By Charlie Youlden | December 15, 2025

SpaceX Ignites a Trillion-Dollar Push to Reach Mars by 2028 SpaceX is edging closer to what could be the first human mission to Mars by late 2028, according to recent company commentary. The more interesting question is how they plan to fund such an ambitious leap. The answer is probably not what most people expect.…

Read More

Here are 6 ASX Resources Stocks With Feasibility Studies due in 2026!

By Nick Sundich | December 15, 2025

This article outlines 6 ASX Resources Stocks With Feasibility Studies due in 2026! The companies mentioned in this article are hitting what are arguably the most pivotal points in their history. Many have existing resources but this will give investors an idea of how much money could be made from the project, as well as…

Read More

Peter Warren Automotive (ASX:PWR): When will be its time to shine? Maybe it will be 2026 (if the market recovers)

By Nick Sundich | December 15, 2025

Peter Warren Automotive (ASX:PWR) has not had the best tenure on the ASX with its market cap of <$300m – a far cry from its all time peak of >$500m. But after bottoming out in March 2025, shares have been on the upwards ever since. And while its performance has lagged its peers, we think…

Read More

Is South32 a Buy After Macquarie’s Upgrade? Here’s What Investors Need to Know

By Ujjwal Maheshwari | December 15, 2025

South32 (ASX: S32) climbed 3.6% on Friday after Macquarie upgraded the stock to Outperform with an A$3.70 price target. The broker pointed to improved returns and a favourable commodity backdrop as reasons for the bullish shift. For investors watching the ASX resources space, this upgrade comes at an interesting time. Silver has surged 119% year-to-date, copper…

Read More

Alcoa (ASX:AAI) Doubles From 52-Week Low: Buy the Breakout or Take Profits?

By Ujjwal Maheshwari | December 15, 2025

Alcoa’s (ASX: AAI) share price has almost doubled from its 52-week low of A$36.20 and is now trading around A$58. The stock hit a high of A$73.21 earlier this year before pulling back, but the business keeps getting stronger. Record smelter production, aluminium prices at their highest level in three years, and a major gallium…

Read More

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

Chimeric Therapeutics (ASX:CHM) is headed for the CAR-T ‘Big Time’

Chimeric Therapeutics (ASX:CHM) We spoke to Dr Rebecca McQualter, CEO of Chimeric Therapeutics (ASX:CHM), about the…

Alma Metals (ASX:ALM) plans to ride the long term copper wave

Alma Metals (ASX: ALM) We spoke to Dr Frazer Tabeart, CEO of Alma Metals (ASX: ALM),…

WIN Metals’ (ASX:WIN) Radio Gold project is music to our ears!

WIN Metals (ASX:WIN) We spoke to Steve Norregaard, CEO of WIN Metals (ASX:WIN), about the company’s…

AuMega Metals (ASX:AAM) aims to build a monster gold project in Canada: Interview with CEO Pazuki

AuMega Metals (ASX:AAM) We spoke to Sam Pazuki, CEO of AuMega Metals (ASX:AAM), about the company’s…

Investment Glossary

Small Cap Company

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

All Ordinaries Index

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity?

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Securities

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

IPO

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.